Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    August 2019
  1. LI F, Guo H, Yang Y, Feng M, et al
    Autophagy modulation in bladder cancer development and treatment (Review).
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7286.
    PubMed     Text format     Abstract available


    July 2019
  2. TOLLE A, Buckendahl L, Jung K
    Plasma miR15b5p and miR5905p for distinguishing patients with bladder cancer from healthy individuals.
    Oncol Rep. 2019 Jul 24. doi: 10.3892/or.2019.7247.
    PubMed     Text format     Abstract available


  3. WANG F, Li Y, Shan F, Zhang Q, et al
    Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7246.
    PubMed     Text format     Abstract available


    June 2019
  4. XUE Y, Tong L, LiuAnwei Liu F, Liu A, et al
    Tumorinfiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7196.
    PubMed     Text format     Abstract available


    May 2019
  5. SUN X, Song J, Li E, Geng H, et al
    ()Epigallocatechin3gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
    Oncol Rep. 2019 May 24. doi: 10.3892/or.2019.7170.
    PubMed     Text format     Abstract available


    March 2019
  6. CHENG H, Hao Y, Gao Y, He Y, et al
    PLCepsilon promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7056.
    PubMed     Text format     Abstract available


  7. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Intravesical treatment of chemotherapeutic agents sensitizes bacillus CalmetteGuerin by the modulation of the tumor immune environment.
    Oncol Rep. 2019;41:1863-1874.
    PubMed     Text format     Abstract available


    February 2019
  8. SEKINO Y, Sakamoto N, Ishikawa A, Honma R, et al
    Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039.
    PubMed     Text format     Abstract available


  9. ZHUO Z, Song Z, Ma Z, Zhang Y, et al
    Chlorophyllin e6mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells.
    Oncol Rep. 2019 Feb 14. doi: 10.3892/or.2019.7013.
    PubMed     Text format     Abstract available


  10. HO JN, Byun SS, Lee SE, Youn JI, et al
    Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatinresistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Oncol Rep. 2019 Feb 11. doi: 10.3892/or.2019.7005.
    PubMed     Text format     Abstract available


    December 2018
  11. JING J, Liu J, Wang Y, Zhang M, et al
    The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6937.
    PubMed     Text format     Abstract available


  12. LI F, Sun Y, Jia J, Yang C, et al
    Silibinin attenuates TGFbeta1induced migration and invasion via EMT suppression and is associated with COX2 downregulation in bladder transitional cell carcinoma.
    Oncol Rep. 2018;40:3543-3550.
    PubMed     Text format     Abstract available


    November 2018
  13. ZHANG J, Mao S, Wang L, Zhang W, et al
    MicroRNA154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7.
    Oncol Rep. 2018 Nov 21. doi: 10.3892/or.2018.6879.
    PubMed     Text format     Abstract available


  14. LIU CP, Zhang JH, Zheng SC, Liu J, et al
    A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
    Oncol Rep. 2018;40:2826-2835.
    PubMed     Text format     Abstract available


  15. LEBRUN L, Milowich D, Le Mercier M, Allard J, et al
    UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
    Oncol Rep. 2018;40:2497-2506.
    PubMed     Text format     Abstract available


    October 2018
  16. WANG P, Zhang Y, Zhang J, Jiang J, et al
    IL23 concentrationdependently regulates T24 cell proliferation, migration and invasion and is associated with prognosis in patients with bladder cancer.
    Oncol Rep. 2018 Oct 8. doi: 10.3892/or.2018.6775.
    PubMed     Text format     Abstract available


    September 2018
  17. WU K, Mu XY, Jiang JT, Tan MY, et al
    miRNA26a5p and miR26b5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
    Oncol Rep. 2018 Sep 26. doi: 10.3892/or.2018.6734.
    PubMed     Text format     Abstract available


    August 2018
  18. XU ZL, Zhang Y, Wang L, Li F, et al
    B7H3 promotes malignant progression of muscleinvasive bladder cancer.
    Oncol Rep. 2018 Aug 17. doi: 10.3892/or.2018.6655.
    PubMed     Text format     Abstract available


  19. GAO F, Wang X, Chen S, Xu T, et al
    CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6641.
    PubMed     Text format     Abstract available


    July 2018
  20. ZHANG H, Qi D, Li J, Peng T, et al
    A novel regulatory circuit of miR152 and DNMT1 in human bladder cancer.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6553.
    PubMed     Text format     Abstract available


  21. ZHANG T, Yang F, Li W, Liu B, et al
    Suppression of the SDF1/CXCR4/betacatenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Oncol Rep. 2018 Jul 4. doi: 10.3892/or.2018.6546.
    PubMed     Text format     Abstract available


    May 2018
  22. LI WL, Yu HY, Zhang XJ, Ke M, et al
    Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6421.
    PubMed     Text format     Abstract available


    April 2018
  23. CHEN D, Xu J, Zhang Q
    Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
    Oncol Rep. 2018 Apr 5. doi: 10.3892/or.2018.6359.
    PubMed     Text format     Abstract available


  24. XIAO J, Niu S, Zhu J, Lv L, et al
    miR223p enhances multichemoresistance by targeting NET1 in bladder cancer cells.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6355.
    PubMed     Text format     Abstract available


    March 2018
  25. LIU X, Kong C, Zhang Z
    miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Oncol Rep. 2018 Mar 6. doi: 10.3892/or.2018.6300.
    PubMed     Text format     Abstract available


  26. LIU S, Jiang H, Wen H, Ding Q, et al
    Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6294.
    PubMed     Text format     Abstract available


    January 2018
  27. MA J, Ge J, Xue X, Xiu W, et al
    Targeting bladder cancer using activated T cells armed with bispecific antibodies.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6211.
    PubMed     Text format     Abstract available


    December 2017
  28. TAKAMURA T, Horinaka M, Yasuda S, Toriyama S, et al
    FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
    Oncol Rep. 2017 Dec 1. doi: 10.3892/or.2017.6127.
    PubMed     Text format     Abstract available


    September 2017
  29. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    PubMed     Text format     Abstract available


  30. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    PubMed     Text format     Abstract available


  31. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    PubMed     Text format     Abstract available


    August 2017
  32. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    PubMed     Text format     Abstract available


  33. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    PubMed     Text format     Abstract available


    July 2017
  34. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    PubMed     Text format     Abstract available


    June 2017
  35. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    PubMed     Text format     Abstract available


  36. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    PubMed     Text format     Abstract available


  37. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    PubMed     Text format     Abstract available


    May 2017
  38. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    PubMed     Text format     Abstract available


    April 2017
  39. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    PubMed     Text format     Abstract available


  40. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    PubMed     Text format     Abstract available


    March 2017
  41. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    PubMed     Text format     Abstract available


    January 2017
  42. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    PubMed     Text format     Abstract available


    December 2016
  43. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    PubMed     Text format     Abstract available


    October 2016
  44. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    PubMed     Text format     Abstract available


  45. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    PubMed     Text format     Abstract available


    September 2016
  46. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    PubMed     Text format     Abstract available


    August 2016
  47. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    PubMed     Text format     Abstract available


    July 2016
  48. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    PubMed     Text format     Abstract available


    May 2016
  49. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: